Core Viewpoint - The stock of Meihao Medical (301363) has experienced a decline, with a closing price of 23.41 yuan on October 23, 2025, down 1.76% from the previous day [1] Financial Performance - For Q3 2025, Meihao Medical reported a main revenue of 1.194 billion yuan, a year-on-year increase of 3.28% [3] - The net profit attributable to shareholders was 208 million yuan, a year-on-year decrease of 19.25% [3] - The net profit excluding non-recurring items was 203 million yuan, down 17.85% year-on-year [3] - The company's gross margin stood at 39.34% [3] Stock Performance and Market Sentiment - On October 23, 2025, the stock had a turnover rate of 2.16%, with a trading volume of 80,700 hands and a transaction amount of 190 million yuan [1] - The net outflow of main funds was 18.576 million yuan, accounting for 9.76% of the total transaction amount [1] - Over the past 90 days, 17 institutions rated the stock, with 15 buy ratings and 2 hold ratings, and the average target price set at 25.2 yuan [4] Industry Comparison - Meihao Medical's total market value is 13.317 billion yuan, compared to the industry average of 11.613 billion yuan [3] - The company's price-to-earnings ratio (P/E) is 47.97, significantly lower than the industry average of 119.45 [3] - The return on equity (ROE) for Meihao Medical is 5.79%, compared to the industry average of 1.95% [3]
股票行情快报：美好医疗（301363）10月23日主力资金净卖出1857.60万元